Platelet factor XIIIa release during platelet aggregation and plasma clot strength measured by thrombelastography in patients with coronary artery disease treated with clopidogrel

References

• Bagoly Z, Koncz Z, Hársfalvi J, Muszbek L. Factor XIII, clot structure, thrombosis. Thromb Res 2012;129:382–387
   PubMed Web of Science ®Google Scholar
• Schroeder V, Chatterjee T, Kohler HP. Influence of blood coagulation factor XIII and FXIII Val34Leu on plasma clot formation measured by thrombelastography. Thromb Res 2001;104:467–474
   PubMedGoogle Scholar
• Levy JH, Greenberg C. Biology of factor XIII and clinical manifestations of factor XIII deficiency. Transfusion 2013;53:1120–1131
   PubMedGoogle Scholar
• Inbal A, Lubetsky A, Krapp T, Castel D, Shaish A, Dickneitte G, Modis L, Muszbek L, Inbal A. Impaired wound healing in factorXIII deficient mice. Thromb Haemost 2005;94:432–437
   PubMedGoogle Scholar
• Dardik R, Loscalzo J, Inbal A. Factor XIII (FXIII) and angiogenesis. J Thromb Haemost 2006;4:19–25
   PubMed Web of Science ®Google Scholar
• Adány R, Bárdos H. Factor XIII subunit A as an intracellular transglutaminase. Cell Mol Life Sci 2003;60:1049–1060
   PubMedGoogle Scholar
• Ádány R. Intracellular factor XIII: Cellular distribution of factor XIII subunit A in humans. Semin Thrombos Haemostas 1996;22:399–408
   PubMedGoogle Scholar
• Sixma JJ, van den Berg A, Schiphorst M, Gezue JH, McDonagh J. Immunocytochemical localization of albumin and factor XIII in thin cryo sections of human blood platelets. Throm Haemost 1984;51:388–391
   PubMedGoogle Scholar
• Dashty M, Akbarkhanzadeh V, Zeebregts CJ, Spek CA, Sijbrands EJ, Peppelenbosch MP, Rezaee F. Characterization of coagulation factor synthesis in nine human primary cell types. Sci Rep 2012;2(787):1–9
   Google Scholar
• Kasahara K, Kaneda M, Miki T, Iida K, Sekino-Suzuki N, Kawashima I, Suzuki H, Shimonaka M, Arai M, Ohno-Iwashita Y, et al. Clot retraction is mediated by factor XIII-dependent fibrin-αIIbβ3-myosin axis in platelet sphingomyelin-rich membrane rafts. Blood 2013;122:3340–3348
   PubMed Web of Science ®Google Scholar
• Gurbel PA, Bliden KP, Guyer K, Cho PW, Zaman KA, Kreutz RP, Bassi AK, Tantry US. Platelet reactivity in patients and recurrent events post-stenting: Results of the PREPARE POST-STENTING Study. J Am Coll Cardiol 2005;46:1820–1826
   PubMed Web of Science ®Google Scholar
• Bitar A, Kreutz RP. Role of thrombelastography (TEG) in risk assessment and guidance of antithrombotic therapy in patients with coronary artery disease. Drug Dev Res 2013;74:533–540
   Google Scholar
• Magwenzi SG, Ajjan RA, Standeven KF, Parapia LA, Naseem KM. Factor XIII supports platelet activation and enhances thrombus formation by matrix proteins under flow conditions. J Thromb Haemost 2011;9:820–833
   PubMed Web of Science ®Google Scholar
• Kreutz RP, Tantry US, Bliden KP, Gurbel PA. Inflammatory changes during the ‘common cold' are associated with platelet activation and increased reactivity of platelets to agonists. Blood Coagul Fibrinolysis 2007;18:713–718
   PubMedGoogle Scholar
• Kreutz RP, Alloosh M, Mansour K, Neeb Z, Kreutz Y, Flockhart DA, Sturek M. Morbid obesity and metabolic syndrome in Ossabaw miniature swine are associated with increased platelet reactivity. Diabetes Metab Syndr Obes 2011;4:99–105
   PubMedGoogle Scholar
• Stone GW, Witzenbichler B, Weisz G, Rinaldi MJ, Neumann FJ, Metzger DC, Henry TD, Cox DA, Duffy PL, Mazzaferri E, et al. ADAPT-DES Investigators. Platelet reactivity and clinical outcomes after coronary artery implantation of drug-eluting stents (ADAPT-DES): A prospective multicentre registry study. Lancet 2013;382:614–623
   PubMed Web of Science ®Google Scholar
• Kreutz RP, Owens J, Breall JA, Lu D, von der Lohe E, Bolad I, Sinha A, Flockhart DA. C-reactive protein and fibrin clot strength measured by thrombelastography after coronary stenting. Blood Coagul Fibrinolysis 2013;24:321–326
   PubMedGoogle Scholar
• McDonagh J, McDonagh RP Jr, Delâge JM, Wagner RH. Factor XIII in human plasma and platelets. J Clin Invest 1969;48:940–946
   PubMedGoogle Scholar
• Nielsen VG, Gurley WQ Jr, Burch TM. The impact of factor XIII on coagulation kinetics and clot strength determined by thrombelastography. Anesth Analg 2004;99:120–123
   PubMedGoogle Scholar
• Zacho M, Rafiq S, Kelbæk H, Johansson PI, Nielsen MB, Steinbrüchel DA, Kofoed KF. Hypercoagulability in relation to coronary artery bypass graft patency and clinical outcome. Scand Cardiovasc J 2013;47:104–108
   PubMed Web of Science ®Google Scholar
• Lu D, Owens J, Kreutz RP. Plasma and whole blood clot strength measured by thrombelastography in patients treated with clopidogrel during acute coronary syndromes. Thromb Res 2013;132:e94–e98
   PubMedGoogle Scholar
• Nagy B Jr, Simon Z, Bagoly Z, Muszbek L, Kappelmayer J. Binding of plasma factor XIII to thrombin-receptor activated human platelets. Thromb Haemost 2009;102:83–89
   PubMedGoogle Scholar
• Cordell PA, Kile BT, Standeven KF, Josefsson EC, Pease RJ, Grant PJ. Association of coagulation factor XIII-A with Golgi proteins within monocyte-macrophages: Implications for subcellular trafficking and secretion. Blood 2010;115:2674–2681
   PubMed Web of Science ®Google Scholar
• Holme PA, Brosstad F, Solum NO. The difference between platelet and plasma FXIII used to study the mechanism of platelet microvesicle formation. Thromb Haemost 1993;70:681–686
   PubMed Web of Science ®Google Scholar
• Mueller T, Dieplinger B, Poelz W, Calatzis A, Haltmayer M. Utility of whole blood impedance aggregometry for the assessment of clopidogrel action using the novel Multiplate analyzer – Comparison with two flow cytometric methods. Thromb Res 2007;121:249–258
   PubMed Web of Science ®Google Scholar
• Jin J, Daniel JL, Kunapuli SP. Molecular basis for ADP-induced platelet activation. II. The P2Y1 receptor mediates ADP-induced intracellular calcium mobilization and shape change in platelets. J Biol Chem 1998;273:2030–2034
   PubMed Web of Science ®Google Scholar